indomethacin 3-hydrohypropylamide

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: indomethacin 3-hydrohypropylamide
• 英文别名: 2-{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methylindol-3-yl}-N-(3-hydroxypropyl)acetamide；1-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetamido]-3-hydroxy-n-propane；Indomethacin 3-Hydroxypropylamide；2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]-N-(3-hydroxypropyl)acetamide
• 化学式: C₂₂H₂₃ClN₂O₄
• 分子量: 414.889
• InChiKey: JKOWVRMWEPTPOD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.7
• 重原子数：
  29
• 可旋转键数：
  7
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.27
• 拓扑面积：
  80.6
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  (((1S)-(4-chlorophenoxy)-(1-methyl)oxycarbonylethyl)amino)phosphinyl chloride 、 indomethacin 3-hydrohypropylamide 在 N-甲基咪唑 作用下， 以 四氢呋喃 为溶剂， 反应 12.0h， 以41%的产率得到C₃₂H₃₄Cl₂N₃O₈P
  参考文献：
  名称：

  The novel phosphoramidate derivatives of NSAID 3-hydroxypropylamides: Synthesis, cytostatic and antiviral activity evaluations

  摘要：

  The target phosphoramidates 5a-e were prepared in one step from 3-hydroxypropyl derivatives 3a-e of nonsteroidal anti-inflammatory drugs (fenoprofen, ketoprofen, ibuprofen, indomethacin, diclofenac). The products 3a-e and 5a-e were evaluated for their cytostatic and antiviral activity against malignant tumour cell lines and normal human fibroblasts (WI 38). All phosphoramidate derivatives 5a-e possess significantly greater inhibitory activities than the corresponding 3-hydroxypropyl derivatives 3a-e, whereby compound 5a showed the most potent inhibitory activities against cervical, pancreatic and colon carcinoma cell lines (IC50 = 5 - 7 mu M), (C) 2008 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2008.03.037
• 作为产物：
  描述：

  吲哚美辛 、 3-氨基-1-丙醇 在 4-二甲氨基吡啶 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 三乙胺 作用下， 以 二氯甲烷 为溶剂， 以68%的产率得到indomethacin 3-hydrohypropylamide
  参考文献：
  名称：

  Structure-Based Design, Synthesis, and Biological Evaluation of Indomethacin Derivatives as Cyclooxygenase-2 Inhibiting Nitric Oxide Donors

  摘要：

  Indomethacin, a nonselective cyclooxygenase (COX) inhibitor, was modified in three distinct regions in an attempt both to increase cyclooxygenase-2 (COX-2) selectivity and to enhance drug safety by covalent attachment of an organic nitrate moiety as a nitric oxide donor. A human whole-blood COX assay shows the modifications on the 3-acetic acid part of the indomethacin yielding an amide-nitrate derivative 32 and a sulfonamide-nitrate derivative 61 conferred COX-2 selectivity. Along with their respective des-nitrate analogs, for example, 31 and 62, the nitrates 32 and 61 were effective antiinflammatory agents in the rat air-pouch model. After oral dosing, though, only 32 increased nitrate and nitrite levels in rat plasma, indicating that its nitrate tether served as a nitric oxide donor in vivo. In a rat gastric injury model, examples 31 and 32 both show a 98% reduction in gastric lesion score compared to that of indomethacin. In addition, the nitrated derivative 32 inducing 85% fewer gastric lesions when coadministered with aspirin as compared to the combination of aspirin and valdecoxib.

  DOI：

  10.1021/jm0611861

文献信息

• Esters and amides containing the
  申请人：Dr. Karl Thomae GmbH

  公开号：US04362738A1

  公开（公告）日：1982-12-07

  Compounds of the formula ##STR1## wherein each X, which may be identical or different from the other X, is oxygen or imino; R.sub.1 is hydrogen, fluorine, chlorine or bromine; R.sub.2 and R.sub.3, which may be identical or different from each other, are each hydrogen; unsubstituted or mono-substituted alkyl of 1 to 6 carbon atoms, where the substituent is phenyl or dialkylamino with 1 to 3 carbon atoms in each alkyl moiety; pyridyl; or cycloalkyl of 5 to 7 carbon atoms; R.sub.2 and R.sub.3, together with each other and the nitrogen atoms to which they are attached, are pyrrolidino, piperidino, hexamethyleneimino, morpholino, N-aryl-piperazino or N-(alkyl of 1 to 3 carbon atoms)-piperazino; A is cycloalkylene of 5 to 7 carbon atoms; unsubstituted or substituted alkylene of 2 to 10 carbon atoms, where the substituents are one to two alkyls of 1 to 3 carbon atoms each, one to two carbalkoxys of 2 to 4 carbon atoms each, one to two phenyls, one to four hydroxyls, one halomethyl, one hydroxymethyl, one alkanoyloxy of 1 to 18 carbon atoms, one alkanoyloxymethyl of 1 to 18 carbon atoms in the alkanoyl moiety or one ##STR2## where R.sub.1, R.sub.2 and R.sub.3 have the meanings previously defined; or alkylene of 2 to 10 carbon atoms interrupted by oxygen, sulfur, sulfoxide, sulfonyl, phenyl, cyclohexyl, pyridyl, piperazino or unsubstituted or substituted imino, where the substituent on the imino group is alkyl of 1 to 6 carbon atoms, phenyl or phenylalkyl of 1 to 3 carbon atoms in the alkyl moiety; B is the acyl residue of an antiphlogistic carboxylic acid; and their non-toxic, pharmacologically acceptable acid addition salts. The compounds as well as their salts are useful as anti-inflammatories.

  公式##STR1##的化合物，其中每个X可以相同也可以不同于其他X，是氧或亚胺；R.sub.1是氢，氟，氯或溴；R.sub.2和R.sub.3，可以相同也可以相互不同，都是氢；未取代或单取代的1到6碳原子的烷基，其中取代基是苯基或1到3碳原子的二烷基氨基；吡啶基；或5到7碳原子的环烷基；R.sub.2和R.sub.3，与彼此以及它们所连接的氮原子一起，是吡咯烷基，哌啶基，己亚胺基，吗啉基，N-芳基哌嗪基或N-(1到3碳原子的烷基)哌嗪基；A是5到7碳原子的环烷基；未取代或取代的2到10碳原子的亚烷基，其中取代基是一到两个每个含有1到3碳原子的烷基，一到两个每个含有2到4碳原子的碳烷氧基，一到两个苯基，一到四个羟基，一个卤甲基，一个羟甲基，一个1到18碳原子的烷酰氧基，一个在烷酰基部分含有1到18碳原子的烷酰氧甲基或一个##STR2##其中R.sub.1，R.sub.2和R.sub.3具有先前定义的含义；或2到10碳原子的亚烷基，通过氧，硫，亚砜，磺酰基，苯基，环己基，吡啶基，哌嗪基或未取代或取代的亚胺基中断，其中亚胺基上的取代基是1到6碳原子的烷基，苯基或1到3碳原子的苯烷基；B是一种抗炎的羧酸的酰基残基；以及它们的非毒性，药理学上可接受的酸加成盐。这些化合物以及它们的盐可以用作抗炎药。
• Neue Benzoylderivate, deren Herstellung und deren Verwendung als Arzneimittel
  申请人：Dr. Karl Thomae GmbH

  公开号：EP0024282A1

  公开（公告）日：1981-03-04

  Benzoylderivate der allgemeinen Formel in der X ein Sauerstoffatom oder die Iminogruppe, R, ein Wasserstoff- oder Halogenatom, R2 und R3 Wasserstoffatome. Alkyl-, Cycloalkyl-, Phenylalkyl- oder Pyridylgruppen oder zusammen eine cyclische Iminogruppe, A eine Cycloalkylengruppe, eine gegebenenfalls substituierte Alkylengruppe oder eine Alkylengruppe, die durch einen Sauerstoff- oder Schwefelatom, eine Sulfoxid-, Sulfonyl-, Imino-, Benzol-, Cyclohexan-, Pyridin- oder Piperazinogruppe unterbrochen ist, und B den Acylrest eines Antiphlogisticums bedeuten, und deren physiologisch verträgliche Säureadditionssalze, welche wertvolle pharmakologische Eigenschaften aufweisen, insbesondere bei überraschend geringen Nebenwirkungen eine entzündungshemmende Wirkung. Die Verbindungen der Formel I können nach für analoge Verbindungen üblichen Verfahren hergestellt werden.

  通式如下的苯甲酰衍生物 中的 X 是氧原子或亚氨基、 R，氢原子或卤素原子、 R2 和 R3 是氢原子。R2 和 R3 是氢原子，R4 和 R5 是烷基、环烷基、苯烷基或吡啶基，或者是一个环状亚氨基、 A 是环亚烷基、任选取代的亚烷基或被氧原子或硫原子打断的亚烷基、亚砜基、磺酰基、亚氨基、苯基、环己烷基、吡啶基或哌嗪基，以及 B 是消炎剂的酰基残基及其与生理相容的酸加成盐，它们具有重要的药理特性，特别是消炎效果，而且副作用出奇地小。 式 I 的化合物可以通过类似化合物的常规方法制备。
• WO2006/99416
  申请人：——

  公开号：——

  公开（公告）日：——
• US4362738A
  申请人：——

  公开号：US4362738A

  公开（公告）日：1982-12-07
• Structure-Based Design, Synthesis, and Biological Evaluation of Indomethacin Derivatives as Cyclooxygenase-2 Inhibiting Nitric Oxide Donors
  作者：Shiow-Jyi Wey、Michael E. Augustyniak、Edward D. Cochran、James L. Ellis、Xinqin Fang、David S. Garvey、David R. Janero、L. Gordon Letts、Allison M. Martino、Terry L. Melim、Madhavi G. Murty、Steward K. Richardson、Joseph D. Schroeder、William M. Selig、A. Mark Trocha、Roseanne S. Wexler、Delano V. Young、Irina S. Zemtseva、Brian M. Zifcak

  DOI：10.1021/jm0611861

  日期：2007.12.13

  Indomethacin, a nonselective cyclooxygenase (COX) inhibitor, was modified in three distinct regions in an attempt both to increase cyclooxygenase-2 (COX-2) selectivity and to enhance drug safety by covalent attachment of an organic nitrate moiety as a nitric oxide donor. A human whole-blood COX assay shows the modifications on the 3-acetic acid part of the indomethacin yielding an amide-nitrate derivative 32 and a sulfonamide-nitrate derivative 61 conferred COX-2 selectivity. Along with their respective des-nitrate analogs, for example, 31 and 62, the nitrates 32 and 61 were effective antiinflammatory agents in the rat air-pouch model. After oral dosing, though, only 32 increased nitrate and nitrite levels in rat plasma, indicating that its nitrate tether served as a nitric oxide donor in vivo. In a rat gastric injury model, examples 31 and 32 both show a 98% reduction in gastric lesion score compared to that of indomethacin. In addition, the nitrated derivative 32 inducing 85% fewer gastric lesions when coadministered with aspirin as compared to the combination of aspirin and valdecoxib.